Journal of applied genetics
Carfilzomib resistance in multiple myeloma: A comparative metabolomic analysis.
Krzysztof Żyłka, Magdalena Łuczak, Magdalena Kostrzewska-Poczekaj, Kinga Bednarek, Arnold Bolomsky, Tadeusz Kubicki, Małgorzata Jarmuż-Szymczak, Heinz Ludwig, Dominik Dytfeld
Published: 202510.1007/s13353-025-01022-x
Abstract
Proteasome inhibitors are currently at the forefront of multiple myeloma (MM) treatment. Drug resistance in MM challenges treatment, causing relapses and making the disease incurable. Urgent strategies are needed to combat resistance and understand i…
Preview only. Read the full abstract at the source